Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Axcella Health Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 38 | 35 | −3 |
| Shares | 24.3M | 24.0M | −240.5K (−1.0%) |
| Value | $97.3M | $71.6M | −$25.7M (−26.4%) |
New holders (2)
Institutions that held Axcella Health Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 25,155 | $75.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 893 | $3.00K | 0.00% |
Sold out (5)
Institutions that held Axcella Health Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Trust Advisors LP | 45,013 | $181.0K |
| ExodusPoint Capital Management, LP | 33,424 | $134.0K |
| Charles Schwab Investment Management Inc | 10,305 | $42.0K |
| Royal Bank of Canada | 4,593 | $18.0K |
| New York State Common Retirement Fund | 109 | $0 |